These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35406645)

  • 1. Designing Personalized Antigen-Specific Immunotherapies for Autoimmune Diseases-The Case for Using Ignored Target Cell Antigen Determinants.
    Tian J; Song M; Kaufman DL
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined therapy with GABA and proinsulin/alum acts synergistically to restore long-term normoglycemia by modulating T-cell autoimmunity and promoting β-cell replication in newly diabetic NOD mice.
    Tian J; Dang H; Nguyen AV; Chen Z; Kaufman DL
    Diabetes; 2014 Sep; 63(9):3128-34. PubMed ID: 25146474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-based therapies using ignored determinants of beta cell antigens can more effectively inhibit late-stage autoimmune disease in diabetes-prone mice.
    Olcott AP; Tian J; Walker V; Dang H; Middleton B; Adorini L; Washburn L; Kaufman DL
    J Immunol; 2005 Aug; 175(3):1991-9. PubMed ID: 16034144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of New Onset Type 1 Diabetes by Oral
    Mbongue JC; Rawson J; Garcia PA; Gonzalez N; Cobb J; Kandeel F; Ferreri K; Husseiny MI
    Front Immunol; 2019; 10():320. PubMed ID: 30863412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining anti-IL-7Rα antibodies with autoantigen-specific immunotherapy enhances non-specific cytokine production but fails to prevent Type 1 Diabetes.
    Vazquez-Mateo C; Collins J; Goldberg SJ; Lawson M; Hernandez-Escalante J; Dooms H
    PLoS One; 2019; 14(3):e0214379. PubMed ID: 30908554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.
    Chen C; Lee WH; Yun P; Snow P; Liu CP
    J Immunol; 2003 Jul; 171(2):733-44. PubMed ID: 12847240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
    Durinovic-Belló I
    Autoimmunity; 1998; 27(3):159-77. PubMed ID: 9609134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1β produced in response to islet autoantigen presentation differentiates T-helper 17 cells at the expense of regulatory T-cells: Implications for the timing of tolerizing immunotherapy.
    Bertin-Maghit S; Pang D; O'Sullivan B; Best S; Duggan E; Paul S; Thomas H; Kay TW; Harrison LC; Steptoe R; Thomas R
    Diabetes; 2011 Jan; 60(1):248-57. PubMed ID: 20980463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-based immunotherapy drives the precocious development of autoimmunity.
    Tian J; Olcott AP; Kaufman DL
    J Immunol; 2002 Dec; 169(11):6564-9. PubMed ID: 12444168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of autoimmune diabetes in non-obese diabetic mice requires interleukin-21-dependent activation of autoreactive CD8⁺ T cells.
    Chen XL; Bobbala D; Rodriguez GM; Mayhue M; Chen YG; Ilangumaran S; Ramanathan S
    Clin Exp Immunol; 2013 Aug; 173(2):184-94. PubMed ID: 23607664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes.
    Chen W; Bergerot I; Elliott JF; Harrison LC; Abiru N; Eisenbarth GS; Delovitch TL
    J Immunol; 2001 Nov; 167(9):4926-35. PubMed ID: 11673498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens.
    Kleffel S; Vergani A; Tezza S; Ben Nasr M; Niewczas MA; Wong S; Bassi R; D'Addio F; Schatton T; Abdi R; Atkinson M; Sayegh MH; Wen L; Wasserfall CH; O'Connor KC; Fiorina P
    Diabetes; 2015 Jan; 64(1):158-71. PubMed ID: 25187361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.
    Hancock WW; Polanski M; Zhang J; Blogg N; Weiner HL
    Am J Pathol; 1995 Nov; 147(5):1193-9. PubMed ID: 7485382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin selectively primes Th2 responses and induces regulatory tolerance to insulin in pre-diabetic mice.
    Tian J; Chau C; Kaufman DL
    Diabetologia; 1998 Feb; 41(2):237-40. PubMed ID: 9498660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice.
    Posgai AL; Wasserfall CH; Kwon KC; Daniell H; Schatz DA; Atkinson MA
    Sci Rep; 2017 Feb; 7():42372. PubMed ID: 28205558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of autoreactive CD8+ T cell responses targeting chromogranin A in humanized NOD mice and type 1 diabetes patients.
    Li Y; Zhou L; Li Y; Zhang J; Guo B; Meng G; Chen X; Zheng Q; Zhang L; Zhang M; Wang L
    Clin Immunol; 2015 Jul; 159(1):63-71. PubMed ID: 25958206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope dominance: evidence for reciprocal determinant spreading to glutamic acid decarboxylase in non-obese diabetic mice.
    Zechel MA; Krawetz MD; Singh B
    Immunol Rev; 1998 Aug; 164():111-8. PubMed ID: 9795769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading.
    Prasad S; Kohm AP; McMahon JS; Luo X; Miller SD
    J Autoimmun; 2012 Dec; 39(4):347-53. PubMed ID: 22647732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice.
    Lo J; Xia CQ; Peng R; Clare-Salzler MJ
    J Immunol Res; 2018; 2018():5463879. PubMed ID: 29651443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An oral vaccine for type 1 diabetes based on live attenuated Salmonella.
    Husseiny MI; Rawson J; Kaye A; Nair I; Todorov I; Hensel M; Kandeel F; Ferreri K
    Vaccine; 2014 Apr; 32(20):2300-7. PubMed ID: 24631074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.